CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT — Stella

Recruiting

Back to CMV trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California

Key details

Phase

Safety & dosing

Sponsor

University of California, Irvine

Collaborators

Eurofins Viracor

Enrollment target

~50 participants

Started

June 2024

Primary completion

June 2028

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov